RYSTIGGO
Drug timelines are a Plus or Pro feature.
5 regulatory and trial events tracked for RYSTIGGO, covering 2023-06-26 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Rystiggo (rozanolixizumab) — UCB Pharma
5 regulatory and trial events tracked for RYSTIGGO, covering 2023-06-26 to 2026-08-21. Get the full timeline:
Most recent: EMA Authorised: Rystiggo (rozanolixizumab) — UCB Pharma